Influenza A, pregnancy and neuraminidase inhibitors;Gripe A, embarazo y antivíricos inhibidores de la neuraminidasa

Medicina Clinica

Volumn 136, Issue 15, 2011, Pages 688-693

  Montané, Eva ^a   Lecumberri, Josep ^a   Pedro Botet, María Luisa ^a  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

Antiviral drugs; Influenza A H1N1; Neuraminidase inhibitors; Pregnancy

Indexed keywords

OSELTAMIVIR; SIALIDASE INHIBITOR; ZANAMIVIR;

2009 H1N1 INFLUENZA; DRUG SAFETY; GOVERNMENT; HEALTH CARE ORGANIZATION; HEALTH CARE SYSTEM; PREGNANCY; REVIEW;

ANIMALS; ANTIVIRAL AGENTS; AUSTRALIA; CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); DRUG EVALUATION, PRECLINICAL; DRUG UTILIZATION; EUROPE; FEMALE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; NEURAMINIDASE; NEW ZEALAND; OSELTAMIVIR; PANDEMICS; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; PREGNANCY OUTCOME; RISK ASSESSMENT; UNITED STATES; VIRAL PROTEINS; WORLD HEALTH ORGANIZATION; ZANAMIVIR;

EID: 79956080734     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1016/j.medcli.2010.02.006     Document Type: Review

References (48)

1. Mexico Secretary of Health (2009). Conferencia de Prensa at Secreatria de Salud [consultado 7/5/2009]. Disponible en: http://portal.salud.gob.mx/ contenidos/noticias/influenza/conferencias/conferencia-prensa-070509-mat-03.html
2. López-Cervantes M, Venado A, Moreno A, Pacheco-Domínguez RL, Ortega-Pierres G. On the spread of the novel influenza A (H1N1) virus in Mexico. J Infect Dev Ctries. 2009;3:327-30.
3. CDC. Outbreak of swine-origin influenza A (H1N1) virus infection-Mexico, March-April 2009. MMWR Morb Mortal Wkly Rep. 2009;58. 436-6.
4. CDC update: Novel influenza A (H1N1) virus infections-worldwide. MMWR Morb Mortal Wkly Rep. 2009;58:453-8.
5. WHO. Influenza A (H1N1)-update 45. [consultado 10/6/2009]. Disponible en: http://www.who.int/csr/don/2009-06-08/en/index.html
6. Zimmer SM, Burke DS. Historical perspective-Emergence of influenza A (H1N1) viruses. N Engl J Med. 2009;361:279-85.
7. Morens DM, Taubenberger JK, Fauci AS. The persistent legacy of the 1918 influenza virus. N Engl J Med. 2009;361:225-9.
8. Vaqué Rafart J, Gil Cuesta J, Brotons Agulló M. Main features of the new influenza virus a pandemic (H1N1). Med Clin (Barc). 2009;133:513-21.
9. Ugarte S, Arancibia F, Soto R. Influenza A pandemics: Clinical and organizational aspects: The experience in Chile. Crit Care Med. 2009 [Epub ahead of print].
10. Wilson N, Mason K, Tobias M, Peacey M, Huang QS, Baker M. Interpreting google flu trends data for pandemic H1N1 influenza: The New Zealand experience. Euro Surveill. 2009;14:pii: 19386.
11. Ministerio de Sanidad y Consumo. Información sobre la gripe A/H1N1. Informes de situación. Miércoles 30 de diciembre de 2009. [consultado 19/1/2010]. Disponible en: www.msc.es/servCiudadanos/alertas/ informesGripeA/home.htm
12. European Center for Diseases Prevention and Control. Weekly influenza surveillance overview. 24 December 2009. [consultado 19/1/2010]. Disponible en: http://ecdc.europa.eu/en/publications/Publications/091224-EISN-Weekly-Influenza- Surveillance-Overview.pdf.
13. Centers for Disease Control and Prevention. 2009-2010Seasonal Influenza (Flu)- Weekly report: Influenza summary Update. Influenza Season Week 50 ending December 19, 2009. [consultado 19/1/2010]. Disponible en: http://www.cdc.gov/ flu/weekly/weeklyarchives2009-2010/weekly50.htm.
14. Belshe RB. Implications of the emergence of a novel H1 influenza virus. N Engl J Med. 2009;360:2667-8.
15. Pérez-Padilla R, De la Rosa-Zamboni D, Ponce de León S, Hernández M, Quiñones-Falconi F, Bautista E, et al. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med. 2009;361:680-9.
16. Rello J, Rodríguez A, Ibáñez P, Socias L, Cebrián J, Márques A, et al. Intensive care adult patients with severe respiratory failure caused by influenza A (H1N1) in Spain. Crit Care. 2009;13:R148.
17. Jamieson DJ, Honein MA, Rasmussen SA, Williams JL, Swerdlow DL, Biggerstaff MS, et al. H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet. 2009;374:451-8.
18. Louie JK, Acosta M, Jamieson DJ, Honein MA. Severe 2009 H1N1 influenza in pregnantandpostpartumwomenin California.NEngl JMed.2010. ;362(1):27-35.
19. United States Centers for Disease Control and Prevention. Weekly 2009 H1N1 Flu Media Briefing, October 1, 2009. [consultado 6/10/2009]. Disponible en: http://www.cdc.gov/media/transcripts/2009/t091001.htm
20. Picone O, Ami O, Vauloup-Fellous C, Martínez V, Guillet M, Dupont-Bernabé C, et al. Pandemic influenza A H1N1 2009 flu during pregnancy: Epidemiology, diagnosis and management. J Gynecol Obstet Biol Reprod (Paris). 2009;38:615-28.
21. Moretti ME, Bar-Oz B, Fried S, Koren G. Maternal hyperthermia and the risk for neural tube defects in offspring: Systematic review and meta-analysis. Epidemiology. 2005;16:216-9. (Pubitemid 40314414)
22. Moscona A. Neuraminidase inhibitors for influenza. N Engl J Med. 2005;353:1363-73. (Pubitemid 41362704)
23. Anónimo. Antiviral drugs for influenza. Med Lett Drugs Ther. 2009;51:89-92.
24. Jefferson T, Jones M, Doshi P, Del Mar C. Possible harms of oseltamivir-a call for urgent action. Lancet. 2009;374:1312-3.
25. Toovey S, Rayner C, Prinssen E, Chu T, Donner B, Thakrar B, et al. Assessment of neuropsychiatric adverse events in influenza patients treated with oseltamivir: A comprehensive review. Drug Saf. 2008;31:1097-114.
26. Anónimo. Tamiflu-the wrong message? Drug Ther Bull. 2009;47:97.
27. Jefferson T, Jones M, Doshi P, Del Mar C. Neuraminidase inhibitors for preventing and treating influenza in healthy adults: A systematic review and metaanalysis. BMJ. 2009;339:b5106.
28. Emergency session of the expert committee on the selection and use of essential medicines. [consultado 7/1/2010]. Disponible en: http://www.who.int/ selection-medicines/committees/expert/emergency-session/en/index.html
29. United States Centers for Disease Control and Prevention. 2009-2010 influenza season week 48 ending December 5, 2009. [consultado 15-12-2009]: Disponible en: http://www.cdc.gov/flu/weekly/
30. European Center for Disease Prevention and Control. Oseltamivir-resistant pandemic (H1N1) 2009 influenza virus, October 2009. [consultado 19/11/2009]. Disponible en: http://www.ecdc.europa.eu/en/activities/sciadvice/Lists/ ECDC%20Reviews/ECDC-Dispform.aspx?List=512ff74f-77d4-4ad8-b6d6- bf0f23083f30&ID=683
31. Abe M, Smith J, Urae A, Barrett J, Kinoshita H, Rayner CR. Pharmacokinetics of oseltamivir in young and very elderly subjects. Ann Pharmacother. 2006;40:1724-30. (Pubitemid 44544867)
32. Briggs GG, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation, 8 ed, Philadelphia: Lippincott Williams & Wilkins; 2008.
33. Tanaka T, Nakajima K, Murashima A, García-Bournissen F, Koren G, Ito S. Safety of neuraminidase inhibitors against novel influenza A (H1N1) in pregnant and breastfeeding women. CMAJ. 2009;181:55-8.
34. MHRA. UK Suspected Adverse Drug Reaction (ADR) Analysis influenza antivirals - oseltamivir (Tamiflu) and zanamivir (Relenza). 23 December 2009 [consultado 29/12/2009]. Disponible en: http://www.mhra.gov.uk/ Safetyinformation/Swinefluinformation/index.htm
35. Aoki FY, Hayden FG. Zanamivir. A potent and selective inhibitor of influenza A and B viruses. Clin Pharmacokinet. 1999;36:1-58.
36. Freund B, Gravenstein S, Elliott M, Miller I. Zanamivir: A review of clinical safety. Drug Saf. 1999;21:267-81.
37. United States Centers for Disease Control and Prevention. Interim recommendations for facemask and respirator use to reduce novel influenza A (H1N1) virus transmission. [consultado 25/09/2009]. Disponible en: http://www.cdc.gov/h1n1flu/masks.htm
38. WHO Guidelines for Pharmacological Management of Pandemic (H1N1) 2009 Influenza and other Influenza viruses (20/08/2009). [consultado 07-01-2010]: Disponible en: http://www.who.int/csr/resources/publications/swineflu/h1n1- guidelines-pharmaceutical-mngt.pdf
39. Public health use of influenza antivirals during influenza pandemics (ECDC 18/08/2009). [consultado 7/1/2010]. Disponible en: http://ecdc.europa.eu/ en/publications/Publications/0907-GUI-Public-Health-use-of-Influenza-Antivirals- during-Influenza-Pandemic.pdf
40. Follow-up recommendation from CHMP on oseltamivir and zanamivir. [consultado 7/1/2010]. Disponible en: http://www.emea.europa.eu/humandocs/PDFs/ EPAR/tamiflu/32609509en.pdf
41. Ficha técnica de Tamiflu®. [consultado 7/1/2010]. Disponible en: http://www.emea.europa.eu/humandocs/PDFs/EPAR/tamiflu/emea-combined-h402es. pdf
42. Ficha técnica Relenza®. [consultado 7/1/2010]. Disponible en: http://sinaem4.agemed.es/consaem/especialidad.do?metodo=verFichaWordPdf& codigo=62712&formato=pdf&formulario=FICHAS
43. Centers for Disease Control and Prevention. Updated interim recommendations for obstetric health care providers related to use of antiviral medications in the treatment and prevention of influenza for the 2009-010 season (29/12/2009). [consultado 7/1/2010]. Disponible en: http://www.cdc.gov/h1n1flu/ pregnancy/antiviral-messages.htm
44. Louie JK, Acosta M, Jamieson DJ, Honein MA, the California Pandemic (H1N1) Working Group. Severe 2009 H1N1 influenza in pregnant and postpartum women in California. N Engl J Med. 2009 [Epub ahead of print].
45. AEMPS: actualización de la nota informativa sobre la preparación y administración de oseltamivir y zanamivir en niños menores de 1 año, gestantes y mujeres en período de lactancia, y personas con problemas de deglución. [consultado 19/1/2010]. Disponible en: http://www.agemed.es/actividad/documentos/notasPrensa/docs/2009/ NI-Oseltamivir-Zanamivir-2.pdf
46. Cheng AC, Dwyer DE, Kotsimbos AT, Starr M, Korman TM, Buttery JP, et al. Summary of the Australasian Society for Infectious Diseases and the Thoracic Society of Australia and New Zealand guidelines: Treatment and prevention of H1N1 influenza 09 (human swine influenza) with antiviral agents. Med J Aust. 2009;191:142-5.
47. Nouvelles recommendations sur la prise en charge des patients grippés (10 décembre 2009) [consultado 31/12/2009]. Disponible en: http://www.sante-sports.gouv.fr/nouvelles-recommandations-sur-la-prise-en- charge-des-patients-grippes-10-decembre-2009.html
48. Birnkrant D, Cox E. The emergency use authorization of peramivir for treatment of 2009 H1N1 influenza. N Engl J Med. 2009;361:2204-7.